Safety and costs of initiating Anglotensin Converting Enzyme inhibitors in Primary Care; analysis of individual patient data from studies of left ventricular dysfunction
J Mason
, P Young
, Nick Freemantle
, Frederick Hobbs
Research output: Contribution to journal › Article
18Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Safety and costs of initiating Anglotensin Converting Enzyme inhibitors in Primary Care; analysis of individual patient data from studies of left ventricular dysfunction'. Together they form a unique fingerprint.
Keyphrases
Medicine and Dentistry
Nursing and Health Professions
Pharmacology, Toxicology and Pharmaceutical Science